Literature DB >> 15327767

Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation.

Oronza A Botrugno1, Elisabeth Fayard, Jean-Sébastien Annicotte, Céline Haby, Thomas Brennan, Olivia Wendling, Toshiya Tanaka, Tatsuhiko Kodama, Winston Thomas, Johan Auwerx, Kristina Schoonjans.   

Abstract

LRH-1 is an orphan nuclear receptor predominantly expressed in tissues of endodermal origin, where it controls development and cholesterol homeostasis. We show here that LRH-1 induces cell proliferation through the concomitant induction of cyclin D1 and E1, an effect that is potentiated by its interaction with beta-catenin. Whereas beta-catenin coactivates LRH-1 on the cyclin E1 promoter, LRH-1 acts as a potent tissue-restricted coactivator of beta-catenin on the cyclin D1 promoter. The implication of LRH-1 in cell proliferation highlights an unanticipated crosstalk between LRH-1 and the beta-catenin/Tcf4 signaling pathway, which is relevant for the renewal of intestinal crypt cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15327767     DOI: 10.1016/j.molcel.2004.07.009

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  120 in total

Review 1.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 2.  Emerging actions of the nuclear receptor LRH-1 in the gut.

Authors:  Pablo J Fernandez-Marcos; Johan Auwerx; Kristina Schoonjans
Journal:  Biochim Biophys Acta       Date:  2010-12-29

3.  New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts.

Authors:  Donghui Li; James L Abbruzzese
Journal:  Clin Cancer Res       Date:  2010-07-20       Impact factor: 12.531

4.  Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response.

Authors:  Nicolas Venteclef; Jason C Smith; Bryan Goodwin; Philippe Delerive
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

5.  LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease.

Authors:  Agnes Coste; Laurent Dubuquoy; Romain Barnouin; Jean-Sebastien Annicotte; Benjamin Magnier; Mario Notti; Nadia Corazza; Maria Cristina Antal; Daniel Metzger; Pierre Desreumaux; Thomas Brunner; Johan Auwerx; Kristina Schoonjans
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-01       Impact factor: 11.205

6.  Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development.

Authors:  Peili Gu; Bryan Goodwin; Arthur C-K Chung; Xueping Xu; David A Wheeler; Roger R Price; Cristin Galardi; Li Peng; Anne M Latour; Beverly H Koller; Jan Gossen; Steven A Kliewer; Austin J Cooney
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

7.  dTcf/Pangolin suppresses growth and tumor formation in Drosophila.

Authors:  Shilin Song; Diana Andrejeva; Flávia C P Freitas; Stephen M Cohen; Héctor Herranz
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

8.  Protective role of microRNA-219-5p inhibitor against spinal cord injury via liver receptor homolog-1/Wnt/β-catenin signaling pathway regulation.

Authors:  Jie Li; Liqiang Li; Yong Shen
Journal:  Exp Ther Med       Date:  2018-02-01       Impact factor: 2.447

9.  LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer.

Authors:  S Wang; Z Zou; X Luo; Y Mi; H Chang; D Xing
Journal:  Oncogene       Date:  2018-03-16       Impact factor: 9.867

10.  The what, where, when and how of Wnt/β-catenin signaling in pancreas development.

Authors:  L Charles Murtaugh
Journal:  Organogenesis       Date:  2008-04       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.